EU allocates €500 million for COVID vaccines for poor countries

The vaccines will be procured and delivered by UNICEF and the Pan American Health Organization on behalf of COVAX.

[adinserter block=”2″]

The European Union will provide €500 million for the global COVAX initiative, which aims to provide vaccines against the COVID-19 coronavirus for low- and middle-income countries. This is stated in a statement on the website of the European Commission, released on Tuesday, December 15.

For example, the European Investment Bank (EIB) today agreed on the financing of €400 million to support the participation of low- and middle-income countries in the COVAX Advance Market Commitment (COVAX AMC) program.

This rapidly approved funding, guaranteed by the European Fund for Sustainable Development (EFSD), together with a €100 million COVAX AMC grant from the European Commission, will ensure access to COVID-19 vaccines in 92 countries.

“Together with the EU member states, Team Europe has so far allocated over €850 million to COVAX and is the largest donor of COVAX in the European Union. The joint support of the European Commission and the EIB in the amount of €500 million will allow COVAX to make 1 billion doses of vaccines available to people in the shortest possible time. In low- and middle-income countries, ” said European Commission President Ursula von der Leyen.

Agreements between the EU and partner countries in Africa, Asia, the Caribbean, and the Pacific, as well as between the countries of the Eastern and Southern Partnership, already exist under the European Fund for Sustainable Development.

The vaccines will be procured and delivered by UNICEF and the Pan American Health Organization on behalf of COVAX.

As you know, the global COVAX program is headed by the World Health Organization. Its goal is to deliver 2 billion doses by the end of next year to at least 20% of people in the greatest need anywhere in the world.

The day before, it was reported that the EU plans to transfer to poor countries 5% of the 1.3 billion doses of vaccine that the European Union will receive from six pharmaceutical companies that have created drugs against coronavirus.

Leave a Reply

Your email address will not be published. Required fields are marked *